Long-term therapeutic effect of Ruangan Pills on advanced schistosomiasis patients with ascites
- VernacularTitle:软肝丸长程治疗腹水型晚期血吸虫病疗效观察
- Author:
Fujun LUO
;
Zuoping YAO
;
Su YANG
- Publication Type:Journal Article
- Keywords:
Advanced schistosomiasis;
Ascites;
Hepatic fibrosis;
Ruangan pill
- From:
Chinese Journal of Schistosomiasis Control
2014;(1):103-105
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the long-term therapeutic effect of Ruangan pills on advanced schistosomiasis combined with ascites. Methods The data of 54 advanced schistosomiasis patients with ascites were collected,and the patients were divid-ed into two groups namely a treatment group and a control group according to whether taking Ruangan pills. The effective rates,im-provement status of symptoms and levels of serum albumin(ALB)and hyaluronic acid(HA)of the two groups were compared. Re-sults The effective rates of the treatment group and control group were 92.59%and 44.44%,respectively,and the difference be-tween them was statistically significant(P<0.05). After the treatment for 9 and 12 months,the percentages of patients without as-cites and patients with symptom improvement in the treatment group were 77.78%and 92.59%,92.59%and 96.30%,respective-ly,while those in the control group were 29.63%and 37.00%,48.15%and 51.85%,respectively,and the differences between the two groups by different time were all statistical significant(all P<0.05). After the treatment for 9 months,the percentages of patients with the normal levels of ALB and HA were 88.89% and 59.26%,while those in the control group were 40.74% and 14.81%,respectively,and the differences between the two groups were statistically significant(both P < 0.05). Conclusion The long-term treatment of Ruangan pills can not only improve clinical symptoms but also control the ascites recurrence,however, the therapeutic effect and the recurrence rate of ascites in longer-term still need further observation.
